Ashion Analytics Genomic Enabled Medicine Cancer Panel

Aug 18, 2015

Ashion Analytics has launched the Genomic Enabled Medicine (GEM) cancer panel designed to improve cancer care. This cancer panel covers the coding regions of 562 cancer-related genes, and also captures copy number events and structural variations. The panel also produces detailed genomic analysis of a patient's cancer. Employing state-of-the-art tumor (somatic)-germline subtraction technology, the GEM cancer panel approach uncovers true tumor events, said Ashion Analytics in a statement.

More Like This

Jun 27, 2017

DNANexus Mosaic Microbiome Research Platform

Working with the Janssen Human Microbiome Institute, DNANexus has introduced Mosaic, an cloud-based informatics platform to support collaboration on research into the human microbiome. DNANexus is positioning Mosaic as a "virtual ecosystem and innovation accelerator" for academic medical centers, biotech and pharmaceutical companies, technology vendors, and government regulators.

Jun 27, 2017

SeraCare iQ NGS QC Management v2

SeraCare Life Sciences has launched version two of its iQ NGS QC Management software. The software supports laboratories' workflows from sample preparation to variant calling enabling lab managers to review and assess run performance, determine run pass or fail status, and identify potential sources of assay drift that could cause problems, according to the company. The software also generates a report that can be used for audits or inspections. The software integrates with existing data systems like Illumina BaseSpace and LIMS.

Jun 26, 2017

Oxford Nanopore PCR-cDNA and Direct cDNA Sequencing Kits

Oxford Nanopore Technologies has launched a PCR-cDNA Sequencing kit and a Direct cDNA Sequencing to prepare cDNA for nanopore sequencing. The PCR-cDNA kit requires a minimum input of 50 nanograms of RNA and the Direct cDNA kit requires at least 250 nanograms of RNA. Both kits can be used on any RNA with a polyA tail, and both are compatible with barcoding kits to multplex samples.

Jun 26, 2017

Premaitha Health Updated Iona Test

Premaitha Health has updated its Iona noninvasive prenatal test, which now includes the first trimester combined test risk score as an option in its software. The company said that it completed a validation study to show that the Iona test in combination with the first trimester combined screen was as accurate as estimating prior risk using maternal age.

Jun 26, 2017

BloodCenter of Wisconsin's Diagnostic Laboratories hematology test panels

BloodCenter of Wisconsin's Diagnostic Laboratories launched seven hematology genetics test panels. The new panesl include nonmalignant hematology disorders, such as platelet function disorders, inherited thrombocytopenia, and congenital neutropenias.  

Jun 22, 2017

Bio-Rad Droplet Digital PCR-Based Assays

Bio-Rad Laboratories has launched droplet digital PCR Genome Edit Detection assays, which can characterize edits generated by CRISPR-Cas9 or other genome editing tools. The assays use ddPCR technology which increases the signal-to-noise ratio, allowing users to quantify extremely rare edits, even those with frequencies of 0.5 percent and from as little as 5 nanograms of genomic DNA. Users can expect to obtain results within one day.

Jun 21, 2017

Children's Hospital Los Angeles OncoKids

Children's Hospital Los Angeles has launched OncoKids, a next-generation sequencing-based panel that detects mutations, gene amplification, and gene fusions for a full range of pediatric cancers including leukemias, bone and soft tissue tumors, and brain tumors. It only requires a small amount of DNA and RNA (20ng) isolated from fresh, frozen, or formalin-fixed paraffin-embedded tissue. The test was developed in collaboration with Thermo Fisher Scientific and uses the Ion Torrent S5 sequencing platform and Ion AmpliSeq technology.

Jun 19, 2017

Thermo Fisher Scientific ISQ EC Single Quadrupole Mass Spectrometer, MabPac RP 1mm Columns

Thermo Fisher Scientific has launched a new mass spectrometer and new chromatography columns. The ISQ EC Single Quadrupole mass spectrometer integrates with existing ion chromatography and HPLC systems, and the Chromeleon Chromatography Data Software has instrument control for the new mass spec embedded. The MabPac RP 1mm columns are designed for analyzing monoclonal antibodies, fragments, variants, antibody drug conjugates, and proteins using high-performance reversed-phase chromatography. They can operate with small sample volumes at low flow rates for direct injection into a mass spectrometer.

Jun 16, 2017

Premaitha Sage Prenatal Screening Solution

Premaitha Health has launched Sage, a noninvasive prenatal testing solution. The test uses the latest technology to detect placental DNA in maternal blood sample, and uses the company's cloud-based bioinformatics analysis to allow laboratories to upload sequencing data files to the cloud for remote analysis. The panel includes full chromosome analysis. The testing will be available through Yourgene Bioscience Singapore, which was acquired by Premaitha in March.

Jun 15, 2017

TATAA Biocenter GrandPeformance Assays

TATAA Biocenter has launched GrandPerformance assays for expression profiling single circulating tumor cells. The assays' workflow is based on preamplification allowing precise measurements of 96 specific expression markers per cell. They are also optimized for single-cell sensitivity.

Jun 15, 2017

Integrated DNA RhAmp SNP Genotyping Solution

Integrated DNA Technologies has launched its rhAmp SNP Genotyping system to enable researchers to make quick, confident, and cost-effective SNP calls. The system is a single-tube assay that uses a unique RNase H2/DNA polymerase two-enzyme system coupled with RNA-DNA hybrid primers to eliminate non-specific amplification. It also uses primer dimer formation, can be fully automated, and is designed to work on all leading commercially available qPCR platforms.

Jun 14, 2017

Bio-Rad CFX Maestro Software

Bio-Rad Laboratories has launched CFX Maestro Software for CFX Real-Time instruments. It is a complete workflow solution for real-time PCR data collection and analysis that enables researchers to set up and run qPCR experiments with ease, the company said. The software includes tools to support reference gene selection, efficiency-corrected relative normalization, data visualization, statistics, and multiplate analysis.

Jun 14, 2017

OmniSeq Immune Report Card

OmniSeq has launched its Immune Report Card, an immune profiling test designed to help oncologists select the best mono and combination immunotherapy options for patients. The assay integrates five clinical-grade tests that together provide a comprehensive immune profile. The report card includes CD3/8 and PD-L1 immunohistochemistry, PD-L1/2 copy number using in situ hybridization, microsatellite instability testing, mutational burden analysis via Thermo Fisher Scientific's Ion Torrent next-generation sequencing of 409 exon cancer genes, and cross-validated simultaneous gene expression analysis of 54 critical transcripts via targeted RNA-seq using the Oncomine Immune Response Research Assay. The test is approved by the New York State Clinical Laboratory Evaluation Program, the company said.

Jun 12, 2017

DNA Software PanelPlex

DNA Software has released PanelPlex, a cloud-based product designed to aid with multiplexing of molecular diagnostics for infectious disease. Customers may use the product directly through cloud computing, or may opt to have DNA Software conduct design work using the product. Features of the product include automated assay design for a particular species among a panel of its variants and its near neighbors; wet-lab-validated results; and inclusivity and exclusivity "panels" for diagnostic quality design, according to the company's website.

Jun 07, 2017

Prevention Genetics Tests for Female, Male Infertility

Prevention Genetics has launched genetic tests for both female and male infertility. The new infertility sequencing panels cover 83 genes for females and 80 genes for males. They also include chromosomal microarray, Y chromosome deletion testing, and FMR1 CGG repeat expansion for premature ovarian failure. Tests must be ordered through a qualified health provider and will be performed in the company's CLIA- and ISO 15189:2013-accredited laboratory.